171 related articles for article (PubMed ID: 4316120)
1. [How to oversee the treatment of tuberculosis?].
Germouty J; Serizay B; Demonet B; Charles A
Sem Hop; 1970 Jun; 46(27):1911-4. PubMed ID: 4316120
[No Abstract] [Full Text] [Related]
2. Chemotherapy of tuberculosis.
Pinsker KL; Koerner SK
Am J Hosp Pharm; 1976 Mar; 33(3):275-83. PubMed ID: 769544
[TBL] [Abstract][Full Text] [Related]
3. Antituberculous drugs.
Warkany J
Teratology; 1979 Aug; 20(1):133-7. PubMed ID: 92814
[No Abstract] [Full Text] [Related]
4. [Algodystrophy associated with antitubercular chemotherapy: 22 cases].
Deshayes P; Houdent G; Morere P; Lemercier JP; Desseauve P; Simonin JL
Rev Rhum Mal Osteoartic; 1969 Jun; 36(6):316-22. PubMed ID: 4251526
[No Abstract] [Full Text] [Related]
5. Management of tuberculosis in elderly persons.
Nagami P; Yoshikawa TT
Compr Ther; 1984 Jul; 10(7):57-62. PubMed ID: 6540155
[No Abstract] [Full Text] [Related]
6. [Tuberculostatics. General adverse effects].
Mordasini ER; Eulenberger J
Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):499-518. PubMed ID: 4339952
[No Abstract] [Full Text] [Related]
7. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
8. Side effects of drugs used to treat tuberculosis.
Newton RW
Scott Med J; 1975 Mar; 20(2):47-9. PubMed ID: 47648
[No Abstract] [Full Text] [Related]
9. [Toxicity of antitubercular agents for the liver].
Dölle W
Dtsch Med Wochenschr; 1973 Jan; 98(2):74. PubMed ID: 4683834
[No Abstract] [Full Text] [Related]
10. [Electroencephalographic changes and antitubercular treatments].
Piéron R; Gautier H; Duhurt J; Kauffmann JP
Sem Hop; 1972 Oct; 48(40):2585-91. PubMed ID: 4344846
[No Abstract] [Full Text] [Related]
11. [Surveillance and complications of antituberculosis chemotherapy].
Duroux P
Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779
[No Abstract] [Full Text] [Related]
12. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
Knop P; Kindler U; Merholz T
Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
[No Abstract] [Full Text] [Related]
13. Antituberculous agents.
Van Scoy RE; Wilkowske CJ
Mayo Clin Proc; 1987 Dec; 62(12):1129-36. PubMed ID: 3682957
[TBL] [Abstract][Full Text] [Related]
14. [Modern chemotherapy of tuberculosis].
Unholtz K
Munch Med Wochenschr; 1970 May; 112(21):1003-11. PubMed ID: 5467739
[No Abstract] [Full Text] [Related]
15. [Side effects of tuberculostatics (author's transl)].
Favez G; Wiser H
Munch Med Wochenschr; 1973 Sep; 115(39):1685-90. PubMed ID: 4801051
[No Abstract] [Full Text] [Related]
16. [Standard therapy of tuberculosis].
Orlowski EH
Dtsch Med J; 1971 Jan; 22(1):17-8. PubMed ID: 5549215
[No Abstract] [Full Text] [Related]
17. Adverse drug reactions in TB therapy: risks and recommendations.
Yoshikawa TT; Nagami PH
Geriatrics; 1982 Jul; 37(7):61-8. PubMed ID: 7084671
[No Abstract] [Full Text] [Related]
18. Adverse cutaneous reactions to antituberculosis drugs.
Holdiness MR
Int J Dermatol; 1985 Jun; 24(5):280-5. PubMed ID: 2410379
[No Abstract] [Full Text] [Related]
19. [Allergy to antitubercular agents; with special reference to new drugs].
Mühlberger F
Schweiz Med Wochenschr; 1973 Jan; 103(4):126-31. PubMed ID: 4119096
[No Abstract] [Full Text] [Related]
20. Adverse drug reactions observed during DOTS.
Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
